These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21878571)
1. Why do influenza virus subtypes die out? A hypothesis. Palese P; Wang TT mBio; 2011; 2(5):. PubMed ID: 21878571 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of the influenza A virus H5N1 subtype and memory of immunity to the H2N2 subtype. Terajima M; Babon JA; Ennis FA mBio; 2012; 3(4):. PubMed ID: 22782524 [No Abstract] [Full Text] [Related]
3. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Pica N; Hai R; Krammer F; Wang TT; Maamary J; Eggink D; Tan GS; Krause JC; Moran T; Stein CR; Banach D; Wrammert J; Belshe RB; García-Sastre A; Palese P Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2573-8. PubMed ID: 22308500 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus. Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849 [TBL] [Abstract][Full Text] [Related]
6. The influenza virus hemagglutinin head evolves faster than the stalk domain. Kirkpatrick E; Qiu X; Wilson PC; Bahl J; Krammer F Sci Rep; 2018 Jul; 8(1):10432. PubMed ID: 29992986 [TBL] [Abstract][Full Text] [Related]
7. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354 [TBL] [Abstract][Full Text] [Related]
8. Pandemic influenza vaccines: what they have taught us about B cell immunology. Topham DJ; Nguyen P; Sangster MY Curr Opin Immunol; 2018 Aug; 53():203-208. PubMed ID: 29957457 [TBL] [Abstract][Full Text] [Related]
9. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
10. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
12. Software for Characterizing the Antigenic and Genetic Evolution of Human Influenza Viruses. Reimering S; McHardy AC Methods Mol Biol; 2018; 1836():551-565. PubMed ID: 30151591 [TBL] [Abstract][Full Text] [Related]
13. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase. Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573 [TBL] [Abstract][Full Text] [Related]
14. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies. Kirchenbaum GA; Carter DM; Ross TM J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834 [TBL] [Abstract][Full Text] [Related]
15. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance. Chen YQ; Lan LY; Huang M; Henry C; Wilson PC J Virol; 2019 Feb; 93(4):. PubMed ID: 30518651 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection. Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756 [TBL] [Abstract][Full Text] [Related]
17. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin. Lee JM; Eguia R; Zost SJ; Choudhary S; Wilson PC; Bedford T; Stevens-Ayers T; Boeckh M; Hurt AC; Lakdawala SS; Hensley SE; Bloom JD Elife; 2019 Aug; 8():. PubMed ID: 31452511 [TBL] [Abstract][Full Text] [Related]
18. Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine. Coughlan L; Palese P Cell Host Microbe; 2018 Jul; 24(1):18-24. PubMed ID: 30001520 [TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection. Walters KA; Zhu R; Welge M; Scherler K; Park JK; Rahil Z; Wang H; Auvil L; Bushell C; Lee MY; Baxter D; Bristol T; Rosas LA; Cervantes-Medina A; Czajkowski L; Han A; Memoli MJ; Taubenberger JK; Kash JC mBio; 2019 May; 10(3):. PubMed ID: 31088926 [TBL] [Abstract][Full Text] [Related]
20. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses. Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]